Kiai Parsa 4

What Happened

• Kiai Parsa, a Medifast, Inc. (MED) director, received two awards of restricted stock units on May 26, 2026. The grants were for 11,680 RSUs and 7,637 RSUs (total 19,317 RSUs) reported at $0.00 (award/compensation). These units represent the right to receive one share each and will vest in full on May 26, 2027. This is an award (compensation) rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-26; Filing date: 2026-05-28 (timely Form 4 filing).
• Transaction code: A (award/grant/acquisition); reported acquisition price: $0.00.
• Total units granted: 11,680 + 7,637 = 19,317 RSUs.
• Vesting: units vest in full on May 26, 2027 (per plan).
• Shares owned after transaction: not specified in the information provided in this summary.
• Footnotes: Grants were made under the Medifast Director's Deferred Compensation Plan and stem from the company’s Amended and Restated 2012 Share Incentive Plan. The RSUs were elected by the director in lieu of cash compensation for annual director fees.

Context

• These awards are part of routine non-employee director compensation and do not represent an open-market buy or sale. RSUs convert to common stock upon vesting; until vested they are subject to the plan terms. Such awards are common for directors and reflect compensation, not necessarily a direct signal of insider sentiment.